chrX-12885782-G-A
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_016562.4(TLR7):c.274G>A(p.Val92Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000727 in 1,210,292 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 32 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016562.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TLR7 | NM_016562.4 | c.274G>A | p.Val92Ile | missense_variant | 3/3 | ENST00000380659.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TLR7 | ENST00000380659.4 | c.274G>A | p.Val92Ile | missense_variant | 3/3 | 1 | NM_016562.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000892 AC: 10AN: 112097Hom.: 0 Cov.: 23 AF XY: 0.000117 AC XY: 4AN XY: 34285
GnomAD3 exomes AF: 0.000191 AC: 35AN: 183259Hom.: 0 AF XY: 0.000177 AC XY: 12AN XY: 67755
GnomAD4 exome AF: 0.0000710 AC: 78AN: 1098195Hom.: 0 Cov.: 32 AF XY: 0.0000770 AC XY: 28AN XY: 363551
GnomAD4 genome AF: 0.0000892 AC: 10AN: 112097Hom.: 0 Cov.: 23 AF XY: 0.000117 AC XY: 4AN XY: 34285
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.274G>A (p.V92I) alteration is located in exon 3 (coding exon 2) of the TLR7 gene. This alteration results from a G to A substitution at nucleotide position 274, causing the valine (V) at amino acid position 92 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
TLR7-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 17, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 13, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at